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Abstract
Thanks to the increasing availability of drug-drug interactions (DDI) datasets and large
biomedical knowledge graphs (KGs), accurate detection of adverse DDI using machine learning
models becomes possible. However, it remains largely an open problem how to effectively
utilize large and noisy biomedical KG for DDI detection. Due to its sheer size and amount of
noise in KGs, it is often less beneficial to directly integrate KGs with other smaller but higher
quality data (e.g., experimental data). Most of existing approaches ignore KGs altogether. Some
tries to directly integrate KGs with other data via graph neural networks with limited success.
Furthermore most previous works focus on binary DDI prediction whereas the multi-typed DDI
pharmacological effect prediction is more meaningful but harder task.
To fill the gaps, we propose a new method SumGNN: knowledge summarization graph neural
network, which is enabled by a subgraph extraction module that can efficiently anchor on rele-
vant subgraphs from a KG, a self-attention based subgraph summarization scheme to generate
reasoning path within the subgraph, and a multi-channel knowledge and data integration module
that utilizes massive external biomedical knowledge for significantly improved multi-typed DDI
predictions. SumGNN outperforms the best baseline by up to 5.54%, and performance gain is
particularly significant in low data relation types. In addition, SumGNN provides interpretable
prediction via the generated reasoning paths for each prediction.
*Equal Contribution
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1 Introduction
Adverse drug-drug interactions (DDI) are modifications of the effect of a drug when administered
with another drug, which is a common and dangerous scenario for patients with complicated
conditions. Undetected adverse DDIs have become serious health threats and caused nearly
74, 000 emergency room visits and 195, 000 hospitalizations each year in the United States
alone (Percha and Altman, 2013). To mitigate these risks and costs, accurate prediction of DDIs
becomes a clinically important task. Two types of data are being utilized for developing DDI
detection models: Manually curated DDI networks and large biomedical knowledge graphs.
Curated DDI networks: Researchers have curated DDI networks based on experimental datasets
and literature such as TWOSIDES (Tatonetti et al., 2012), MINER (Zitnik et al., 2018b) and
DrugBank (Wishart et al., 2008; Ryu et al., 2018). These curated data are of higher quality but
expensive to create and usually smaller in size.
Knowledge Graph: Over the years, large knowledge graph (KG) such as (Rotmensch et al.,
2017), Hetionet (Himmelstein and Baranzini, 2015) and DRKG (Ioannidis et al., 2020) have been
constructed from literature mining and database integration. However, these KGs are large and
noisy: out of their tens of thousands of nodes with millions of edges, only a small subgraph is
relevant to a prediction target.
Deep Learning: Graph neural networks (GNN) have achieved great performance by casting DDI
prediction as a link prediction problem on DDI graphs (Gysi et al., 2020; Zitnik et al., 2018a;
Huang et al., 2020a; Lin et al., 2020). However, existing DL models are often trained only based
on the DDI dataset at hand, ignoring the large biomedical knowledge graph (Ioannidis et al., 2020;
Himmelstein and Baranzini, 2015) which can benefit the DDI predictions since DDI is driven by
complicated biomedical mechanism. Some recent works (Karim et al., 2019; Lin et al., 2020)
tried to integrate knowledge graph into the DDI prediction via direct integration of standard KG
and GNN methods. But DDI prediction presents unique modeling difficulties since the input
KG is large and noisy while the pertinent information for a drug pair is local. Moreover, most
existing works also only make binary classification - predicting the presence of DDIs, despite that
predicting the particular DDI type is a more meaningful task.
Our Approach. In this work, we propose a new method SumGNN that efficiently uses KG to
aid drug interaction prediction. SumGNN enjoys improved predictive performance, efficiency,
inductiveness and interpretability. SumGNN provides the following technical contributions:
1. Local subgraph for identifying useful information. We use local subgraph in the KG
around drug pairs to extract useful information, instead of the entire KG. The subgraph
formulation allows noise reduction by anchoring on relevant information and is highly
scalable since the message passing receptive field is significantly decreased.
2. Subgraph summarization scheme for generating reasoning path. We then propose a
summarization scheme to generate mechanism pathway for drug interactions. We develop
a layer-independent self-attention mechanism to generate signal intensity score for each
edge in the subgraph and create a KG pathway that has high scores. This pathway provides
insights on the biological processes that drive drug interactions.
3. Multi-channel data and knowledge integration for improved multi-typed DDI predic-
tions. We propose to use multi-channel neural encoding to aggregate diverse set of data
sources, ranging from the summarized subgraph embedding to chemical structures. It
enables utilization of massive external biomedical knowledge for significantly improved
multi-typed DDI predictions. In addition, the neural encoding takes different subgraph in
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each propagation, forming an inductive bias that promotes generalizability in low-resource
DDI types.
We conduct extensive experiments to show SumGNN improves DDI prediction significantly.
It has up to 5.54% increase over the best baseline while the inference time is greatly reduced.
Moreover, SumGNN excels at low-resource settings whereas previous works do not. SumGNN is also
able to provide reasonable clues about the underlying mechanism of the drug interactions.
2 Related Works
External knowledge graph integration. Recently, several efforts have attempted to leverage
the KG for downstream tasks such as recommendation (Wang et al., 2019a,b; Gao et al., 2019),
information extraction (Wang et al., 2018; Liang et al., 2020; Yu et al., 2020b) and drug interaction
prediction (Celebi et al., 2019; Karim et al., 2019; Lin et al., 2020). (Celebi et al., 2019; Karim
et al., 2019; Dai et al., 2020) project each entity and relation to a dense vector with knowledge
graph embedding techniques (Bordes et al., 2013; Su et al., 2020; Trouillon et al., 2016) and
then feed them to neural networks for prediction. However, they do not directly harness the
neighborhood information for target entities during inference, thus the external knowledge
information are not sufficiently exploited. (Lin et al., 2020) adopts graph convolutional networks
with neighborhood sampling to explicitly model the neighborhood relations with higher inference
speed. However, as each neighboring entity could play a crucial role in the drug interaction
mechanism, random sampling could potentially dropout these important factors and hinders the
prediction performance. In contrast, SumGNN provides a learnable way to extract useful information
in the neighborhood. In addition, the previous works all focus on binary DDI prediction whereas
SumGNN evaluates on multi-type relation network.
Subgraph Graph Neural Network. Graph neural networks have been (Kipf and Welling,
2017; Velicˇkovic´ et al., 2018; Schlichtkrull et al., 2018; Yu et al., 2020a; Srinivasa et al., 2020)
proposed for modeling the relation between nodes and have been successfully applied to various
domains (Shi et al., 2020; Yu et al., 2020c; Shang et al., 2019). Subgraph structure contains rich
information for many graph learning tasks (Teru and Hamilton, 2020; Velicˇkovic´ et al., 2019;
Huang and Zitnik, 2020). For instance, Ego-CNN applies local ego network to identify structures
for graph classification (Tzeng and Wu, 2019). Alsentzer et al. (2020) formulate a multi-channel
way to subgraph classification. Cluster-GCN (Chiang et al., 2019) and GraphSAINT (Zeng et al.,
2020) use subgraphs to improve GNN scalability. More relevant to us, Zhang and Chen (2018)
apply local subgraph for link prediction and Teru and Hamilton (2020) extend this idea into KG
completion task via utilizing multi-relational information. In contrast, driven by the domain DDI
prediction problem, SumGNN is the first to apply a graph summarization method on subgraphs to
obtain tractable pathway and also with a new multi-channel neural encoding mechanism.
3 Method
We present SumGNN in this section. We summarize problem settings in Section 3.1 and describe
our method in detail in Section 3.2. Our method can be decomposed into three modules. First, we
use local subgraph in the KG around drug pairs to extract useful information. We then propose a
summarization scheme to generate mechanism pathway for drug interactions. Then, we describe
a multi-channel neural encoding layer to predict the pharmacological effect.
3
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Figure 1: SumGNN illustration.
3.1 Problem Settings
Definition 1 (Drug Interaction Graph). Given drugs D and pharmacological effects R𝐷 ,
the drug interaction graph G𝐷𝐷𝐼 is defined as a set of triplets G𝐷𝐷𝐼 = {(𝑢, 𝑟, 𝑣) | 𝑢 ∈ D, 𝑟 ∈
R𝐷 , 𝑣 ∈ D)}, where each triplet (𝑢, 𝑟, 𝑣) represents that drug 𝑢 and drug 𝑣 have pharmacological
effect 𝑟.
Definition 2 (External Biomedical Knowledge Graph). Given a set of various biomedical
entities Eand the biomedical relation among the entitiesR, the external biomedical knowledge
graph G𝐾𝐺 is defined as G𝐾𝐺 = {(ℎ, 𝑟, 𝑡) | ℎ, 𝑡 ∈ E, 𝑟 ∈ R} with each item (ℎ, 𝑟, 𝑡) describes a
biomedical relation 𝑟 between entity ℎ and entity 𝑡. Note that we aggregate the drug entities in
G𝐷𝐷𝐼 to G𝐾𝐺 , i.e.,R𝐷 ∈ R, and D ∈ E.
Problem 1 (Multi-relational DDI Prediction). The Drug-drug interaction (DDI) prediction is
to output the pharmacological effect given the a pair of drugs. Mathematically, it is to learn a
mapping F : D× D→ R𝐷 from a drug pair (𝑢, 𝑣) ∈ (D× D) to the pharmacological effect
𝑟 ∈ R𝐷 .
3.2 The SumGNNMethod
SumGNN is composed of three modules: subgraph anchoring, knowledge summarization, and
multi-channels neural encoding. For a given drug pairs, we anchor to a subgraph of potential
biomedical entities that are close to the pairs in the KG. Then, we propose a new graph neural
network that has a summarization scheme to provide a condense pathway to reason about drug
interaction mechanism. Given this pathway graph, we use multi-channels neural encoding, to
integrate diverse sources of available information to generate a sufficient drug pair representation.
At last, a decoding classifier is followed to predict the interaction outcome. We initialize all entity
embedding using KG method TransE (Bordes et al., 2013), where a entity is denoted as h(0)𝑢 .
(A) The Local Subgraph Extraction Module
The biomedical KG describes the complicated mechanism of human biology. Modulation in
several nodes (drug-pairs) in the KG can perturb the connected nodes (e.g. disease, cellular
component, and etc.) which creates a ripple effect that eventually result in various physiological
outcomes. The effect is diffused as distance between the drug pairs and the biomedical entities
increases. Thus, to understand the drug interactions, we focus on local subgraphs in the KG
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around the drug pairs. Specifically, for drug pairs 𝑢 and 𝑣, we first extract the 𝑘-hop neighboring
nodes for both 𝑢 and 𝑣,N𝑘 (𝑢) = {𝑠 | 𝑑 (𝑠, 𝑢) ≤ 𝑘} and N𝑘 (𝑣) = {𝑠 | 𝑑 (𝑠, 𝑣) ≤ 𝑘}, where 𝑑 (·, ·)
stands for the distance between two nodes on G𝐾𝐺 . Then, we obtain the enclosing subgraph
based on the intersection of these nodes, G𝑆𝑢𝑏 = {(𝑢, 𝑟, 𝑣) | 𝑢, 𝑣 ∈ N𝑘 (𝑢) ∩N𝑘 (𝑣), 𝑟 ∈ R}.
Motivated by (Zhang and Chen, 2018) which highlights the importance of node relative
position to the central node 𝑢, 𝑣 in the subgraph as capturing the rich structural information. Thus,
we augment the initial node embedding in the subgraph by concatenating a position vector. For
each node 𝑖, we compute the shortest path length (𝑑 (𝑖, 𝑢), 𝑑 (𝑖, 𝑣)) between 𝑖 and the center drug
pairs nodes 𝑢, 𝑣. We convert it into a position vector p𝑖 = [one-hot(𝑑 (𝑖, 𝑢)) ⊕ one-hot(𝑑 (𝑖, 𝑣))].
Then, we update the node 𝑖 representation as h(0)𝑖 = [h(0)𝑖 , p𝑖].
(B) The Knowledge Summarization Module
To provide biological insights in addition to the predictive outcome, we design a knowledge
summarization module to summarize the subgraph information into a pathway for potential drug
interactions. This summarization means that we need to retrieve paths that contain signals for
the interactions while remove paths that are not important. To achieve this, we adopt a layer-
independent relation-aware self-attention to assign a weight for every edges in G𝑆𝑢𝑏. These
weights are generated based on the input featurization h(0) and represent the interaction signal
intensities for edge pruning.
We denote the interaction signal intensity score 𝛼𝑖, 𝑗 as the edge connecting any biomedical
entity 𝑖 and 𝑗 . Inspired by the relation-aware transformer architecture (Shaw et al., 2018), we
use self-attention mechanism, which takes account into all nodes in the subgraph to generate
the attention weight. This attention mechanism is ideal for us because it means that the signal
intensity score is generated after examining all biomedical entities in the subgraph around the
drug-pairs. Here, 𝛼𝑢,𝑣 is calculated as
𝛼𝑖, 𝑗 = Threshold
©­«𝜎 ©­«
h(0)𝑗 W𝐽 (h(0)𝑖 W𝐼 + r𝑖 𝑗)𝑇√
𝑑𝑘
ª®¬ , 𝛾ª®¬ , (1)
where theW𝐽 andW𝐼 are the self-attention key weights that contain representation for each node
in the subgraph, 𝑟𝑖 𝑗 encodes the relationship between the two nodes 𝑖 and 𝑗 ,
√
𝑑𝑘 is the size of
feature vector h(0) for normalization, 𝛾 is the signal threshold and 𝜎(𝑥) = 𝑒𝑥−𝑒−𝑥𝑒𝑥+𝑒−𝑥 is the tanh
function for non-linear transformation.
Intuitively, this function first computes the dot product between h(0)𝑖 andW𝐼 to get attention
score between node 𝑖 and every other node in the subgraph. Then we sum it up with the relation
embedding, followed up the same procedure to calculate attention score between node 𝑗 and
every other node through dot product between h(0)𝑗 andW𝐽 . By taking the dot product with every
other nodes for both 𝑖, 𝑗 , the final score leverages considers all the subgraph information. Then,
after non-linear transformation, we obtain the signal intensity score ranging from −1 to 1 for
this edge. At last, we apply a threshold function to screen out edges that are below an intensity
score threshold 𝛾 by setting them with weight 0 since they are not important for the interaction
prediction and setting them 0 would prune these edges from message passing in the graph neural
network. This step is applied to every edge in the subgraph.
Note that existing graph attention approaches (Velicˇkovic´ et al., 2018; Cai and Lam, 2020;
Shaw et al., 2018) generate attention weights for every edge in every layer. However, this way
can provide potentially contradicting signals across layers for the same edge, precluding the
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generation of interpretable pathways. In the contrast, SumGNN adopts a layer-independent attention
mechanism, which only depends on the fixed input embedding to prune edges first. It applies an
unequivocal pathway for model explainability.
(C) The Multi-Channel Integration Module
To obtain a powerful representation for drug interaction prediction, we integrate a diverse set of
information sources.
Channel 1: Summarized Knowledge Using the knowledge summarization, we identify a sum-
marized subgraph that is important to input drug pairs. We want to generate latent representation
that leverage this subgraph for the input drug pairs. We integrate it using the following message
passing scheme. For a node 𝑣, we compute a relation-aware message weighted by the signal
intensity score b𝑙𝑣 at layer 𝑙 using
b(𝑙)𝑣 =
∑︁
𝑢∈N𝑣
𝛼 (𝑙)𝑢,𝑣
(
h(𝑙−1)𝑢 W(𝑙)𝑟
)
, (2)
where N𝑣 denotes the neighbors of node 𝑣 in subgraph G𝑆𝑢𝑏, W(𝑙)𝑟 is the weight matrix to
transform hidden representation for node 𝑢, 𝑣’s relation 𝑟 in layer 𝑙. To avoid overfitting, we use
basis decomposition (Schlichtkrull et al., 2018) to decomposeW(𝑙)𝑟 into the linear combination of
a small number of basis matrices {V𝑏}𝑏∈𝐵 as
W(𝑙)𝑟 =
𝐵∑︁
𝑏=1
𝑎 (𝑙)𝑟𝑏V
(𝑙)
𝑏 . (3)
Then, we propagate the message b(𝑙)𝑣 to the updated representation h(𝑙)𝑣 of node 𝑣 via
h(𝑙)𝑣 = ReLU
(
W(𝑙)selfh
𝑘−1
𝑣 + b(𝑙)𝑣
)
, (4)
whereWself is the weight matrix to transform the node embedding itself.
Channel 2: Subgraph Features To obtain the embeddings for subgraphs (denoted as hG𝑆𝑢𝑏 ), we
take the average of all node embeddings in G𝑆𝑢𝑏 at layer 𝑙 projected by a linear layer as
h(𝑙)
G𝑆𝑢𝑏
= Mean
(
WSubh(𝑙)𝑖
)
. (5)
Channel 3: Drug FingerprintMolecular information such as chemical fingerprints have shown
to be powerful predictor of drug interactions (Huang et al., 2020b). Thus, in addition to the
network representation, we obtain the Morgan fingerprint fv (Rogers and Hahn, 2010), which is a
predictive descriptor of drugs, for each drug 𝑣.
Layer-wise Channels Aggregation To assemble various representation generated via each layer,
we adopt the layer-aggregation mechanism (Xu et al., 2018). We concatenate node/subgraph em-
beddings in every layer, i.e., h𝑣 = [h(1)𝑣 , h(2)𝑣 , · · · , h(𝐿)𝑣 ] and hG𝑆𝑢𝑏 = [h(1)G𝑆𝑢𝑏 , h
(2)
G𝑆𝑢𝑏
, · · · , h(𝐿)
G𝑆𝑢𝑏
]
where is 𝐿 is the layer size. To integrate chemical fingerprints, we update the layer-aggregated
embedding by concatenation of chemical representation: h𝑣 = [h𝑣 ⊕ f𝑣 ].
At last, we combine the various channels together to obtain the input drug-pairs representation
h𝑢,𝑣 = [h𝑢 , h𝑣 , hG𝑆𝑢𝑏 ]. To predict the relation, we obtain a prediction probability vector p𝑢,𝑣
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where each value in the vector corresponds to a the likelihood of a relation. p𝑢,𝑣 is computed via
feeding the drug pair representation to a decoder parameterized byWpred:
p𝑢,𝑣 = Wpredh𝑢,𝑣 . (6)
3.2.1 Training and Inference
During training, for multi-class classification task, we adopt the the cross entropy loss ℓCE for
each edge (𝑢, 𝑟, 𝑣) as
ℓCE(𝑢, 𝑟, 𝑣) = −
𝑅∑︁
𝑟=1
log( ?ˆ?𝑟 ) · 𝑦𝑟 (7)
where ?ˆ?𝑟 = softmax(p𝑟𝑢,𝑣 ) = exp(p
𝑟
𝑢,𝑣 )∑𝑅
𝑖=1 exp(p𝑖𝑢,𝑣 )
and 𝑦𝑟 is the binary indicator if class 𝑟 is the correct
label for 𝑢 and 𝑣. For multi-label classification task, given the edge (𝑢, 𝑟, 𝑣), we adopt the binary
cross entropy loss ℓBCE as
ℓBCE(𝑢, 𝑟, 𝑣) = − log ?ˆ?𝑟 − 𝔼𝑤∼𝑃𝑤 (𝑣) log
(
1 − 𝑦𝑢,𝑤𝑟
)
(8)
where (𝑢, 𝑟, 𝑤) is the sampled negative edge for relation 𝑟. This is achieved by replacing node
𝑣 to node 𝑤 that is sampled randomly according to a distribution 𝑃𝑤 (𝑣) ∝ 𝑑𝑤 (𝑣)3/4 (Mikolov
et al., 2013). Then ?ˆ?𝑟 = sigmoid(p𝑟𝑢,𝑣 ), 𝑦𝑢𝑤𝑟 = sigmoid(p𝑟𝑢,𝑤 ) is the prediction score for two
edges. Considering all edges, the final lossL in SumGNN is
L =
∑︁
(𝑢,𝑟 ,𝑣) ∈E
ℓ(𝑢, 𝑟, 𝑣) (9)
where ℓ is either Eq. (7) or Eq. (8) depending on the task type. During training, we learn the
model parameter by minimizing the total loss L using stochastic gradient optimizers such as
Adam (Kingma and Ba, 2014).
During inference, an unseen node pair 𝑢, 𝑣’s subgraph in the KG is extracted and fed into the
same pipeline to calculate the relation vector. For multi-class task, we use the highest probability
relation as the predicted relation and for multi-label task, we collect all scores from both positive
and negative counterparts for all relations.
4 Experiments
4.1 Experiment Setup
Datasets (1) DrugBank dataset (Wishart et al., 2008) contains 1,709 drugs (nodes) and 136,351
drug pairs (edges), which are associated with 86 types of pharmacological relations between
drugs, such as increase of cardiotoxic activity, decrease of serum concentration and etc. Each drug
pair can contain one or two relations. As more than 99.8% of edges have only one edge type (Ryu
et al., 2018), we filtered the edge with more than one type in our study. (2) TWOSIDES (Tatonetti
et al., 2012) dataset contains 645 drugs (nodes) and 46,221 drug-drug pairs (edges) with 200
different drug side effect types as labels. For each edge, it may be associated with multiple
labels. Following (Zitnik et al., 2018a; Dai et al., 2020), we keep 200 commonly-occurring
DDI types ranging from Top-600 to Top-800 to ensure every DDI type has at least 900 drug
combinations. (3) For external knowledge base, we use Hetionet (Himmelstein and Baranzini,
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2015), which is a large heterogeneous knowledge graph merged from 29 public databases. To
ensure no information leakage, we remove all the overlapping DDI edges between Hetionet
and the dataset. In the end, we obtain 33,765 nodes out of 11 types (e.g., gene, disease, pathway,
molecular function and etc.) with 1,690,693 edges from 23 relation types.
BaselinesWe compare our models with several baselines1.
• MLP (Rogers and Hahn, 2010) uses a two-layer MLP on Morgan fingerprint to directly
predict drug interactions.
• Node2vec (Grover and Leskovec, 2016) first learns the embeddings for drugs in the network.
Then, it predict the relation for drug pairs via a linear layer over embeddings.
• Decagon (Zitnik et al., 2018a) adopts multi-relational graph convolutional network (Schlichtkrull
et al., 2018) on the DDI network for drug interaction prediction.
• GAT (Velicˇkovic´ et al., 2018) uses attention networks to aggregate neighborhood information
in DDI network.
• SkipGNN (Huang et al., 2020a) predicts drug interactions by aggregating information from
both direct interactions and second-order interactions via two GNNs.
• KG-DDI (Karim et al., 2019) first extracts KG embeddings for drugs in the KG, then adopts
a Conv-LSTM model using the embeddings for drug interaction prediction.
• GraIL (Teru and Hamilton, 2020) is for inductive relation prediction on KGs, which uses
local subgraph.
• KGNN (Lin et al., 2020) samples and aggregates neighborhoods for each node from their
local receptives via GNN and with external knowledge graph.
Metrics The task on the DrugBank dataset is a multi-class classification, thus we consider the
following metrics:
• Macro F1: average F1 score over different classes as Macro F1 = 1𝑁
∑𝑁
𝑘=1
2𝑃𝑘 ·𝑅𝑘
𝑃𝑘+𝑅𝑘 , where 𝑁
is the # of classes and 𝑃𝑘 , 𝑅𝑘 is the precision and recall for 𝑘-th class.
• Micro F1: weighted average F1 score where the weight of a class is the fraction of samples
of the class out of the entire samples, i.e. Micro F1 =
∑𝑁
𝑘=1
N𝑘
N
2𝑃𝑘 ·𝑅𝑘
𝑃𝑘+𝑅𝑘 , whereN𝑘 , 𝑃𝑘 , 𝑅𝑘 is
the number of samples, precision and recall of class 𝑘 andN is the total size of the dataset.
• Cohen’s Kappa (Cohen, 1960) measures the inter-annotator agreement as 𝜅 = (𝑝𝑜 − 𝑝𝑒) /(1 − 𝑝𝑒) ,
where 𝑝𝑜 is the observed agreement (identical to accuracy), 𝑝𝑒 is the probability of randomly
seeing each class.
The task on the TWOSIDES dataset is a multi-label prediction. We follow (Zitnik et al., 2018a)
and consider the following measure. For each side effect type, we calculate the performance
individually and use the average performance over all side effects as the final result.
• ROC-AUC is the average area under the receiver operating characteristics curve as ROC-AUC =∑𝑛
𝑘=1 TP𝑘 ΔFP𝑘 , where 𝑘 is 𝑘-th true-positive and false-positive operating point (TP𝑘 , FP𝑘).
• PR-AUC is the average area under precision-recall curve PR-AUC =
∑𝑛
𝑘=1 Prec𝑘 ΔRec𝑘
where 𝑘 is 𝑘-th precision/recall operating point (Prec𝑘 ,Rec𝑘).
• AP@50 is the average precision at 50, where AP@𝑘 = |𝑌𝑘∩?ˆ?𝑘 ||𝑌𝑘 | , 𝑌𝑘 is the predicted labels at
𝑘 and 𝑌𝑘 are the ground-truth labels.
1Further details on baseline methods, implementation and parameters are in the supplementary.
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Table 1: SumGNN achieves the best predictive performance compared to state-of-the-art baselines in
DDI prediction. Average and standard deviation of five runs are reported. For these metrics, higher
values always indicate better performance.
Dataset Dataset 1: DrugBank Dataset 2: TWOSIDES
Classification Task Multi-class Multi-label
Methods Macro F1 Micro F1 Cohen’s Kappa ROC-AUC PR-AUC AP@50
MLP (Rogers and Hahn, 2010) 61.10±0.38 82.14±0.33 80.50±0.18 82.60±0.26 81.23±0.14 73.45±0.28
Node2Vec (Grover and Leskovec, 2016) 24.92±0.32 71.09±0.40 63.79±0.37 90.66±0.13 88.87±0.23 83.00±0.30
Decagon (Zitnik et al., 2018a) 57.35±0.26 87.19±0.28 86.07±0.08 91.72±0.04 90.60±0.12 82.06±0.45
GAT (Velicˇkovic´ et al., 2018) 33.49±0.36 77.18±0.15 74.20±0.23 91.18±0.14 89.86±0.05 82.80±0.17
SkipGNN (Huang et al., 2020a) 59.66±0.26 85.83±0.18 84.20±0.16 92.04±0.08 90.90±0.10 84.25±0.25
KG-DDI (Karim et al., 2019) 36.39±0.32 82.48±0.12 78.89±0.27 90.75±0.07 88.16±0.12 83.48±0.05
GraIL (Teru and Hamilton, 2020) 81.31±0.30 89.89±0.24 88.07±0.20 92.89±0.09 91.10±0.19 86.21±0.05
KGNN (Lin et al., 2020) 73.99±0.11 90.89±0.20 89.64±0.24 92.84±0.07 90.78±0.20 86.05±0.12
SumGNN (Ours) 86.85±0.44 92.66±0.14 90.72±0.13 94.86±0.21 93.35±0.14 88.75±0.22
SumGNN-KG 78.35±0.51 89.05±0.36 87.28±0.08 92.62±0.13 90.80±0.40 85.75±0.10
SumGNN-Sum (w/o Summarization) 83.20±0.34 90.83±0.19 90.14±0.10 94.09±0.16 92.55±0.24 87.65±0.24
SumGNN-SF (w/o Subgraph Features) 84.47±0.22 91.88±0.21 90.26±0.19 93.94±0.11 92.45±0.22 87.69±0.08
SumGNN-CF (w/o Chemical Features) 83.57±0.36 91.31±0.17 90.07±0.11 94.35±0.11 92.86±0.20 88.10±0.07
Evaluation Strategy. For both datasets, we split it into 7:1:2 as train, development and test
set. For the DrugBank dataset, since the label distribution is highly imbalanced, we ensure
train/dev/test set contain samples from all classes. For the TWOSIDES dataset, we use the
same method in (Zitnik et al., 2018a) to generate negative counterparts for each positive edge
by sampling the complement set of positive examples. For every experiment, we conduct five
independent runs and select the best performing model based on the loss value on the validation
set.
4.2 Main Results: SumGNN achieves superior performance
We report the performance of our model and all baselines in table 1. From the result, we find that
SumGNN achieves the best performance in DDI prediction on two datasets, accurately predicting the
correct DDI pharmacological effect consistently. Particularly, SumGNN has 27.19%, 5.47%, 4.65%
absolute increase over the best baseline without KG on three metrics respectively on DrugBank
dataset and 2.84%, 2.45%, 4.50% increase on TWOSIDES dataset. Also, SumGNN achieves 5.54%,
1.77%, 1.08% and 1.97%, 2.25%. 2.54% absolute increase over the state-of-the-art baselines with
KG on two datasets. These results clearly verifies the efficacy of our method.
By comparing the latter four methods with the former five methods, we find the use of KG
significantly improves DDI performance, highlighting the necessity of external knowledge usage.
Comparing SumGNN with KGNN and KG-DDI, we show that simply adopting KG embeddings
as well as neighborhood sampling are insufficient to fully harness the KG information, whereas
SumGNN provides the best approach to leverage the external KG and also corroborates with our
motivation that use of subgraph reduces noise and irrelevant information. Although GraIL
also extracts subgraphs for downstream tasks, they merely consider the position information
while neglecting the multi-channel features during information propagation. Therefore, their
performance is still limited for drug interaction prediction. In addition, GraIL does not use
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Figure 2: The average F1 score for different relations with various number of samples in the training
set. Here, the x-axis indicate the number of samples as well as the ratio of classes in this group to
all classes.
any knowledge summarization techniques, which potentially further eliminating the irrelevant
information in the local subgraph.
Another interesting finding is that the improvement of SumGNN is clearly more significant on
DrugBank than TWOSIDES dataset. We take a closer look at this problem and find that the
major difference of these two dataset is that the DrugBank is more imbalanced – more than 30%
of the relation types occurs less than 50 times in the training set while more than 10% of the
relation types occurs more than 1000 times. To examine the model’s prediction performance
on the size of training data associated with each relation, we first split the relations types into 5
groups with different number of training data and then plot the average F1 score of these group in
Figure 2. By comparing the performance of SumGNN against the strongest baseline (KGNN) and
the variant of no KG. (Decagon), we find that using KG can effectively boost the performance
when the samples are scarce, as injecting KG can bring at least 38.19% improvement on F1 score
for relations occuring less than 50 times but less than 5% for relations more than 1000 times. In
addition, compared with neighborhood sampling approaches proposed in KGNN, SumGNN can
achieve significantly better performance when the samples are extremely scarce (e.g. few-shot
settings). When the training samples are less than 10, both decagon and KGNN cannot give
correct predictions, while our model can still achieve 57.14% accuracy. One potential reason is
that SumGNN feeds different subgraphs in every GNN propagation, which forms a much-needed
inductive bias over unseen subgraphs. This is in sharp contrast to previous approaches such as
KGNN. It also justifies that SumGNN’s knowledge summarization via subgraphs is more effective
to harness the external knowledge.
4.3 Ablation Study
To study the usage of KG, we remove the knowledge graph (SumGNN-KG) and perform prediction
on the DDI graph. We see SumGNN has 8.5% absolute increase in Macro F1 on DrugBank,
highlighting the usefulness of KG. To evaluate the knowledge summarization module, we remove
the summarization component (SumGNN-Sum) and use the raw local subgraph to predict the
outcome. We see SumGNN has 3.65% increase for DrugBank and 2.24% increase for TWOSIDES
on Macro F1, suggesting that the summarization further condenses the relevant information and
elevate the performance.
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Figure 3: SumGNN generates a short reasoning path to provide clues for understanding drug interac-
tions. Low-weight edges in the extracted subgraph are filtered out by SumGNN and SumGNN focus on
a sparse set of signal edges and nodes.
To study the effect of multi-channel neural encoding, we compare the result of SumGNN with
several variants that remove specific channel information (i.e. subgraph features and chemical
features), and we find that these channel information all contribute to the overall performance.
Particularly, after removing the subgraph embedding (SumGNN-SF), the Macro F1 drops by 2.38%
on DrugBank and 0.92% on TWOSIDES respectively. When removing chemical fingerprint
(SumGNN-CF), the performance also degrades 3.28% on Macro F1 for DrugBank, corroborating
with the indispensable roles of each of the channel.
4.4 Case Study
Using the external knowledge summarization module, we are able to discover signal edges,
which provide biological pathways to hint at the potential mechanism of DDIs. We provide a
case study of a drug pair in the test set, Paroxetine and Hydroflumethiazide. SumGNN accurately
predicts the correct DDI type "increase of the central nervous system depressant activities". We
then visualize the generated pathway from SumGNN’s summarization scheme in Fig 3. We see
that the model significantly reduces irrelevant nodes and edges in the subgraph of the KG and
focuses on a sparse set of nodes to make prediction. We examine the nodes that have high signals
connection to the target pairs and find literature evidence support. Particularly, both drug pairs
connect strongly to two side effects nodes, orthostatic hypotension and aplastic anaemia. Notably,
orthostatic hypotension is closely related to multiple system atrophy, a central nervous system
problem (Jones et al., 2015). As both drugs incur risk in the side effects, they could be aggravated
when these drugs are taken together. This case study illustrates how to use SumGNN for potential
DDI prediction.
4.5 Parameter studies
We study the effect of key parameters. When evaluating one parameter, we fix other parameters
to their default values.
• Effect of the hop of the subgraph 𝑘: Figure 4 shows the result of SumGNN with varying 𝑘 .
From the result, we find that for DrugBank dataset, the performance first increase when 𝑘 is
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Figure 4: Model performance given different parameter 𝑘 .
Table 2: The running time for one epoch of SumGNN for two datasets. Note that w/o Subgraph is a
variant that directly aggregates the information for all neighbors on KG.
Size of Hop 𝑘
Dataset
1 2 3 4
w/o Subgraph
DrugBank 132 s 141 s 178 s 205 s 1279 s
TWOSIDES 62 s 75 s 91 s 102 s 471 s
small. However, when 𝑘 increases from 3 to 4, we observe slight performance drops on Macro F1
score. These indicate that the larger subgraph can bring more useful information while when 𝑘 is
too large, it may also bring some noise and hurt the performance. For TWOSIDES dataset, we
find the result is more stable with different 𝑘 , indicating even 1-hop subgraph provides adequate
information for DDI task.
Moreover, to show how subgraph formulation drives efficiency, we compare the training
time between SumGNN with varying subgraph size and SumGNN with the entire KG to propagate (See
Table 2). We find SumGNN saves 80% of training time via subgraph anchoring, which demonstrates
the efficiency of our approach.
• Effect of the dimension of embeddings 𝑑: Figure 5 exhibits the influence of embedding
dimension 𝑑. The result indicates that when 𝑑 is small, increasing 𝑑 can boost the performance.
But when 𝑑 becomes large, the gain is marginal.
• Effect of the threshold for summarization 𝛾: Figure 6 shows the result of SumGNN with
different threshold 𝛾, which demonstrates that when 𝛾 is small, the performance is rather stable as
filtering edges with low score has little effect on the final prediction. This also means SumGNN is
able to achieve similar predictive performance while removing many irrelevant edges. However,
when 𝛾 is large (𝛾 > 0.4 for DrugBank and 𝛾 > 0.8 for TWOSIDES), it is clear that the
performance drops more. In such cases, the summarized graph is more sparse and we might
filter out potential useful edges. To sum up, there is a trade-off between the explainbility and
performance.
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Figure 6: Model performance given different parameter 𝛾.
5 Conclusion
In this paper, we propose a new method SumGNN: knowledge summarization graph neural network
for multi-typed DDI predictions, which is mainly enabled by a local subgraph module that can
efficiently anchor on relevant subgraphs from a KG, a self-attention based subgraph summarization
scheme that can generate reasoning path within the subgraph, and a multi-channel knowledge
and data integration module that utilizes massive external biomedical knowledge for significantly
improved multi-typed DDI predictions. Experiments on real-world datasets demonstrated the
strong performance of SumGNN.
6 Ethics Statement
Adverse drug interactions incur morbidity and mortality for patients and are also one of the
leading cause for failure of clinical trials, preventing promising life-saving drugs to go to the
market. To test on the combination of all approved drugs in wet-lab setting is unfeasible, thus,
in-silico approaches provide an alternative way to accurately capturing the interactions.
In addition, computational approaches depend heavily on the training data. If the number
of training data associated with one specific drug interaction type is low, it is difficult to predict
accurately. In contrast to other works, SumGNN is able to generate good performance in low-
resource settings. SumGNN is also a general framework and can be adapted to predict any other
interactions such as drug-disease interaction. The ability to low-resource learning could also
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mean to excel at finding drugs for rare diseases.
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A Implementation Details
A.1 SumGNN Parameter Setup
We use the following hyperparameter set for SumGNN after random search on validation set. We use
1, 024-bits Morgan fingerprint for drug featurization. We set the subgraph to be 2-hops neighbors
(i.e. 𝑘 = 2). In the subgraph summarization module, we use weight matrix of size 𝑑 = 32 forW1
andW2. The hidden dimension h𝑘𝑣 is set to be 𝑑 = 32. The relation matrix r is set to be 32. The
edge pruning threshold is set to be 𝛾 = 0. The input hidden representation of each node is 𝑑 = 32.
The number of basis 𝐵 in Eq. (3) is set to 8 as the performance do not change much when set
from 4 to 16 and suffer from over-fitting with 𝐵 > 16. We study the effect of key parameter 𝑑, 𝛾
and 𝑘 in our experiment part (Section 4).
A.2 Training Details
Training Parameters. For both our method and baselines, the training parameters are set as
follows unless specified.
We train the model for 50 epochs with batch size 256. Our model is optimized with ADAM
optimizer (Kingma and Ba, 2014) of learning rate 5 × 10−3 with gradient clipping set to 10 under
L2 norm. We set the L2 weight decay to 1 × 10−5, the layer of GNN to 2 and set the dropout rate
to 0.3 for each Layer in GNN.
Model Implementation and Computing Infrastructure. All methods are implemented in
PyTorch2 and the graph neural network modules are build on Deep Graph Library (DGL)3. The
System we use is Ubuntu 18.04.3 LTS with Python 3.6, Pytorch 1.2 and DGL 0.4.3. Our code is
run in a Intel(R) Core(TM) i7-5930K CPU @ 3.50GHz CPU and a GeForce GTX TITAN X GPU.
A.3 The Range for Tuning Hyper-parameters
We use grid search to determine hyper-parameters and list the search space of key hyper-parameters
as follows.
Table 3: The range for tuning hyper-parameters. The bold numbers are the default settings.
Parameters Range
Learning Rate [5 × 10−4, 1 × 10−3, 5 × 10−3, 1 × 10−2]
Weight Decay [1 × 10−6, 1 × 10−5, 1 × 10−4, 1 × 10−3]
Dropout [0.3, 0.4, 0.5]
Layers of GNN [1, 2, 3]
𝑑 [8, 16, 32, 64]
𝑘 [1, 2, 3, 4]
𝐵 [4, 8, 12, 16, 24, 32]
2https://pytorch.org/
3https://www.dgl.ai/
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A.4 Baseline Setup
For the baselines, the settings are described as follows:
• MLP: We implement MLP with Pytorch with the Morgan fingerprint. We use a two-layer
MLP and set the hidden dimension to 100 with dropout 0.3.
• Node2vec: We follow the officially released implementation from authors4 and set the
embedding dimension to 64.
• Decagon: We use DGL to implement the model. Following (Zitnik et al., 2018a), we set
the number of GNN layers to 2 set the hidden dimension to 64 and 32 for two layers with a
dropout rate of 0.1 and a minibatch size of 512.
• GAT: We use DGL to implement the model and set the hidden dimension to 64 with 4
attention heads, as we find that improving the number of heads will hurt the performance.
We set the activation function to LeakyReLU with 𝛼 = 0.2.
• Others: We follow the officially released implementa- tion from the authors listed as follows:
– SkipGNN: https://github.com/kexinhuang12345/SkipGNN.
– KG-DDI: the neural model is based on code in https://github.com/rezacsedu/
Drug-Drug-Interaction Prediction, and the KG embeddings are trained via OpenKE
toolbox https://github.com/thunlp/OpenKE.
– GraIL: https://github.com/kkteru/grail.
– KGNN: https://github.com/xzenglab/KGNN.
4https://github.com/aditya-grover/node2vec
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